Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

A group of Democratic senators is urging the FAA to keep its requirement that all U.S. airlines carry epinephrine on board. The FAA proposed in August replacing a specific medical kit checklist with broader, performance-based standards — a move lawmakers say could put passengers at risk during in-flight emergencies.
A coalition of Democratic senators, including Tammy Duckworth, Chuck Schumer, and Tammy Baldwin, is pushing back against a Federal Aviation Administration proposal that would loosen requirements for emergency medical kits on commercial flights. Their letter to the FAA stresses that having multiple doses of epinephrine — in formats that can be self-administered without medical training — is "more urgent than ever."
The FAA's August proposal would eliminate a specific checklist of required medical items and instead set performance-based standards, requiring airlines to have sufficient resources to manage nine life-threatening conditions. Critics argue this flexibility could lead airlines to deprioritize life-saving medications like epinephrine, which is critical for treating severe allergic reactions mid-flight.
Key Takeaways:
Why it matters: In-flight medical emergencies can be life-or-death situations with no immediate access to ground-based care. Ensuring standardized, accessible epinephrine on every flight is a critical patient safety issue — and this policy debate could directly affect outcomes for the millions of Americans with severe allergies who fly each year.